Akèy › Degeneresans makile › Texas › Abilene
Etid klinik pou Degeneresans makile nan Abilene, TX
4 etid pou Degeneresans makile ap chèche patisipan nan sit nan ak bò kote Abilene (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)
Ap rekriteFaz 2/3
- Retina Research Institute of Texas (Site 010), Abilene
A Phase 1/2 Study of the Safety and Efficacy of BRX011 Oral Administration Once Daily in Subjects With Geographic Atrophy Secondary to Age-Related Macular Degeneration
Ap rekriteFaz 1/2
- Retina Research Institute of Texas, Abilene
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
Ap rekriteFaz 3
- Retina Research Institute of Texas, Abilene
Study to Assess the Adverse Events and How Intravitreal ABBV-6628 Moves Through the Body of Adult Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration
Ap rekriteFaz 1/2
- Retina Research Institute of Texas /ID# 262141, Abilene
Etid Degeneresans makile nan lòt vil
- Dallas, TX13 etid
- Erie, PA10 etid
- The Woodlands, TX9 etid
- Sacramento, CA8 etid
- Reno, NV8 etid
- Hagerstown, MD8 etid
- Phoenix, AZ7 etid
- Cleveland, OH7 etid
- Houston, TX7 etid
- Salt Lake City, UT7 etid
- Boston, MA7 etid
- Austin, TX7 etid
Lòt etid nan Abilene
- Kansè Poumon ki pa ti selil8 etid
- Kansè nan tete5 etid
- Kansè Metastatik5 etid
- Kansè kolorektal5 etid
- Kansè ovè4 etid
- Kansè tete negatif triple3 etid
- Atrofi Jeyografik3 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.